Differential Immune Responses in Mice Immunized with Recombinant Neutralizing Epitope Protein of Hepatitis E Virus Formulated with Liposome and Alum Adjuvants
- 1 August 2016
- journal article
- research article
- Published by SAGE Publications in Viral Immunology
- Vol. 29 (6) , 350-360
Abstract
In the developing countries, Hepatitis E virus (HEV) is a predominant cause of sporadic acute hepatitis in adults and waterborne epidemics leading to high mortality in pregnant women. Vaccine development mainly focuses on the structural capsid protein open-reading-frame-2 (ORF-2) of the virus. We successfully evaluated liposome-adjuvanted recombinant neutralizing epitope protein (rNEp), a part of ORF-2, 458-607aa, in mice and rhesus macaques. We compared immune response to adjuvants alone, rNEp alone, or adjuvanted with liposome (lipo-rNEp)/alum (al-rNEp) in mice following intramuscular administration of two doses of 5 μg each. IgG anti-HEV titers (enzyme-linked immunosorbent assay), immunophenotyping (flow cytometry, CD3+CD4+, CD3+CD8+, CD11c+, CD11b+, CD19+ cells; costimulatory markers CD80, CD86, MHC-I, MHC-II, and early activation marker CD69), and levels of Th1/Th2 cytokines (IL-2/IFN-γ/IL-4/IL-5 and additionally IL-1β/IL-6/IL-10/TNF for early time points) were determined at early (4/12/24-h postdose-1) and later time points (2 weeks post-both doses). IgG anti-HEV titers were higher in the lipo-rNEp group than al-rNEp post-both doses (p < 0.05). At early time points, cell type proportions were comparable at the site of injection; IL-Iβ levels increased in lipo-rNEp, 24 h, while IL-6 levels rose in lipo-rNEp/al-rNEp/alum-alone groups, 4 h, compared to controls. In the draining lymph nodes (DLNs), CD11c+CD86+ cells increased at 24 h in liposome-alone/lipo-rNEp groups. A rise in the CD11c+CD69+ cells was noted in the lipo-rNEp group compared to other groups (p < 0.05). Cytokine levels in the spleen/sera remained unchanged in all the groups (p > 0.05). At 2 weeks postdose-2, CD11c+MHC-II+/CD11b+MHC-II+ cells increased in the spleen in the lipo-rNEp and al-rNEp groups, respectively. In the DLNs, CD19+MHC-II+ cells increased in rNEp/al-rNEp/lipo-rNEp groups post-both doses and CD11c+CD86+ cells in the lipo-rNEp group. A balanced Th1/Th2 response was evident in the lipo-rNEp, while a Th2 bias was noted in al-rNEp. Different immune response gene clustering patterns were noted in uncultured spleens from immunized mice and cultured-stimulated splenocytes. In conclusion, lipo-rNEp is a better immunogen, works through dendritic cells, and elicits a balanced Th1/Th2 response, while alum functions through macrophages and induces a Th2 response.Keywords
This publication has 45 references indexed in Scilit:
- Modeling the long-term antibody response of a hepatitis E vaccineVaccine, 2015
- Adjuvant Effect of Cationic Liposomes for Subunit Influenza Vaccine: Influence of Antigen Loading Method, Cholesterol and Immune ModulatorsPharmaceutics, 2013
- Disparate adjuvant properties among three formulations of “alum”Vaccine, 2013
- MF59 and Pam3CSK4 Boost Adaptive Responses to Influenza Subunit Vaccine through an IFN Type I-Independent Mechanism of ActionThe Journal of Immunology, 2012
- Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodesVaccine, 2011
- The ABC of clinical and experimental adjuvants—A brief overviewImmunology Letters, 2010
- Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomesVaccine, 2009
- Evaluation of human (genotype 1) and swine (genotype 4)‐ORF2‐based ELISAs for anti‐HEV IgM and IgG detection in an endemic country and search for type 4 human HEV infectionsJournal of Viral Hepatitis, 2006
- Long-term serological follow up and cross-challenge studies in rhesus monkeys experimentally infected with hepatitis E virusJournal of Hepatology, 1999
- Contribution of HEV and HCV in causing fulminant non‐A, non‐B hepatitis in western IndiaJournal of Viral Hepatitis, 1995